Nigrosome and neuromelanin imaging as tools to differentiate parkinson's disease and parkinsonism
Parkinson's disease (PD) lacks a definitive diagnosis due to a lack of pathological validation of patients at antemortem. The risk of misdiagnosis is high in the early stages of PD, often eluded by atypical parkinsonian symptoms. Neuroimaging and laboratory biomarkers are being sought to aid in...
Main Authors: | Deblina Biswas, Rebecca Banerjee, Swagata Sarkar, Supriyo Choudhury, Pritimoy Sanyal, Mona Tiwari, Hrishikesh Kumar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Annals of Indian Academy of Neurology |
Subjects: | |
Online Access: | http://www.annalsofian.org/article.asp?issn=0972-2327;year=2022;volume=25;issue=6;spage=1029;epage=1035;aulast=Biswas |
Similar Items
-
Iron- and Neuromelanin-Weighted Neuroimaging to Study Mitochondrial Dysfunction in Patients with Parkinson’s Disease
by: Benjamin Matis Pizarro-Galleguillos, et al.
Published: (2022-11-01) -
An investigation of neuromelanin distribution in substantia nigra and locus coeruleus in patients with Parkinson’s disease using neuromelanin-sensitive MRI
by: Qiang Liu, et al.
Published: (2023-08-01) -
Melanin and Neuromelanin Fluorescence Studies Focusing on Parkinson’s Disease and Its Inherent Risk for Melanoma
by: Dieter Leupold, et al.
Published: (2019-06-01) -
Neuromelanin in Parkinson’s Disease: Tyrosine Hydroxylase and Tyrosinase
by: Toshiharu Nagatsu, et al.
Published: (2022-04-01) -
Neuromelanin magnetic resonance imaging of substantia nigra and locus coeruleus in Parkinson’s disease with freezing of gait
by: Shangpei Wang, et al.
Published: (2023-02-01)